Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.09 - $1.9 $2,927 - $5,103
-2,686 Reduced 2.48%
105,768 $125,000
Q1 2024

May 15, 2024

BUY
$1.4 - $2.55 $4,393 - $8,001
3,138 Added 2.98%
108,454 $165,000
Q4 2023

Feb 13, 2024

BUY
$1.0 - $3.39 $30,882 - $104,689
30,882 Added 41.49%
105,316 $181,000
Q3 2023

May 14, 2024

SELL
$2.6 - $4.23 $80,293 - $130,630
-30,882 Reduced 29.32%
74,434 $244,000
Q3 2023

Nov 14, 2023

BUY
$2.6 - $4.23 $97,167 - $158,083
37,372 Added 100.84%
74,434 $244,000
Q2 2023

May 14, 2024

SELL
$3.2 - $4.33 $50,796 - $68,734
-15,874 Reduced 29.99%
37,062 $148,000
Q2 2023

Aug 14, 2023

SELL
$3.2 - $4.33 $50,796 - $68,734
-15,874 Reduced 29.99%
37,062 $148,000
Q1 2023

May 14, 2024

BUY
$3.79 - $6.22 $1,838 - $3,016
485 Added 0.92%
52,936 $218,000
Q1 2023

May 11, 2023

BUY
$3.79 - $6.22 $1,838 - $3,016
485 Added 0.92%
52,936 $218,000
Q4 2022

May 14, 2024

SELL
$3.53 - $5.49 $18,013 - $28,015
-5,103 Reduced 8.87%
52,451 $224,000
Q4 2022

Feb 13, 2023

SELL
$3.53 - $5.49 $18,013 - $28,015
-5,103 Reduced 8.87%
52,451 $224,000
Q3 2022

May 14, 2024

SELL
$3.74 - $7.09 $41,042 - $77,805
-10,974 Reduced 16.01%
57,554 $266,000
Q3 2022

Nov 10, 2022

SELL
$3.74 - $7.09 $41,042 - $77,805
-10,974 Reduced 16.01%
57,554 $0
Q2 2022

May 14, 2024

SELL
$4.33 - $7.45 $159,292 - $274,070
-36,788 Reduced 34.93%
68,528 $420,000
Q2 2022

Aug 15, 2022

BUY
$4.33 - $7.45 $90,509 - $155,727
20,903 Added 43.89%
68,528 $420,000
Q1 2022

May 16, 2022

SELL
$5.84 - $13.61 $35,828 - $83,497
-6,135 Reduced 11.41%
47,625 $278,000
Q4 2021

Feb 14, 2022

SELL
$12.52 - $19.02 $15,725 - $23,889
-1,256 Reduced 2.28%
53,760 $698,000
Q3 2021

Nov 10, 2021

BUY
$10.47 - $20.87 $576,017 - $1.15 Million
55,016 New
55,016 $751,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $17.2M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.